JP2023537980A5 - - Google Patents

Info

Publication number
JP2023537980A5
JP2023537980A5 JP2023509770A JP2023509770A JP2023537980A5 JP 2023537980 A5 JP2023537980 A5 JP 2023537980A5 JP 2023509770 A JP2023509770 A JP 2023509770A JP 2023509770 A JP2023509770 A JP 2023509770A JP 2023537980 A5 JP2023537980 A5 JP 2023537980A5
Authority
JP
Japan
Prior art keywords
nucleotide sequence
seq
identity
nucleic acid
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023509770A
Other languages
English (en)
Japanese (ja)
Other versions
JP7860958B2 (ja
JP2023537980A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/072365 external-priority patent/WO2022034130A1/en
Publication of JP2023537980A publication Critical patent/JP2023537980A/ja
Publication of JP2023537980A5 publication Critical patent/JP2023537980A5/ja
Application granted granted Critical
Publication of JP7860958B2 publication Critical patent/JP7860958B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023509770A 2020-08-12 2021-08-11 メチルcpg結合タンパク質2(mecp2)プロモータ配列を含む核酸構築体を用いた遺伝子治療 Active JP7860958B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063064431P 2020-08-12 2020-08-12
US63/064,431 2020-08-12
PCT/EP2021/072365 WO2022034130A1 (en) 2020-08-12 2021-08-11 Gene therapy using nucleic acid constructs comprising methyl cpg binding protein 2 (mecp2) promoter sequences

Publications (3)

Publication Number Publication Date
JP2023537980A JP2023537980A (ja) 2023-09-06
JP2023537980A5 true JP2023537980A5 (cg-RX-API-DMAC7.html) 2024-07-25
JP7860958B2 JP7860958B2 (ja) 2026-05-18

Family

ID=77655525

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023509770A Active JP7860958B2 (ja) 2020-08-12 2021-08-11 メチルcpg結合タンパク質2(mecp2)プロモータ配列を含む核酸構築体を用いた遺伝子治療

Country Status (19)

Country Link
US (1) US20230295657A1 (cg-RX-API-DMAC7.html)
EP (1) EP4196171A1 (cg-RX-API-DMAC7.html)
JP (1) JP7860958B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230044506A (cg-RX-API-DMAC7.html)
CN (1) CN116113441B (cg-RX-API-DMAC7.html)
AR (1) AR123206A1 (cg-RX-API-DMAC7.html)
AU (1) AU2021325717A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023002374A2 (cg-RX-API-DMAC7.html)
CA (1) CA3188748A1 (cg-RX-API-DMAC7.html)
CL (1) CL2023000419A1 (cg-RX-API-DMAC7.html)
CO (1) CO2023000444A2 (cg-RX-API-DMAC7.html)
EC (1) ECSP23016688A (cg-RX-API-DMAC7.html)
IL (1) IL300294A (cg-RX-API-DMAC7.html)
MX (1) MX2023001701A (cg-RX-API-DMAC7.html)
PE (1) PE20230914A1 (cg-RX-API-DMAC7.html)
PH (1) PH12023550145A1 (cg-RX-API-DMAC7.html)
TW (1) TWI902867B (cg-RX-API-DMAC7.html)
WO (1) WO2022034130A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202300378B (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2022131322A1 (cg-RX-API-DMAC7.html) * 2020-12-17 2022-06-23
IL312340A (en) * 2021-10-28 2024-06-01 UCB Biopharma SRL Nucleic acid constructs, viral vectors and viral particles
GB202216168D0 (en) 2022-10-31 2022-12-14 UCB Biopharma SRL Route of administration
WO2024163823A1 (en) * 2023-02-02 2024-08-08 Shape Therapeutics Inc. Tissue-specific enhancers for regulating transcription
JP2026509301A (ja) * 2023-03-14 2026-03-17 ユーシービー バイオファルマ エスアールエル 遺伝子治療
CN121335978A (zh) * 2023-06-16 2026-01-13 舒泰神(北京)生物制药股份有限公司 一种人源MeCp2启动子及其用途
WO2025213097A1 (en) * 2024-04-05 2025-10-09 The Children's Hospital Of Philadelphia Novel gene therapy constructs for stxbp1 haploinsufficiency

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110045536A1 (en) * 2007-12-21 2011-02-24 Novartis Ag Mammalian expression vector
CN104583402A (zh) * 2012-05-16 2015-04-29 Rana医疗有限公司 用于调节mecp2表达的组合物和方法
GB201403684D0 (en) 2014-03-03 2014-04-16 King S College London Vector
CN114717264A (zh) * 2014-11-14 2022-07-08 沃雅戈治疗公司 治疗肌萎缩性侧索硬化(als)的组合物和方法
AU2015349759B2 (en) * 2014-11-21 2022-01-06 The University Of North Carolina At Chapel Hill Aav vectors targeted to the central nervous system
JP6754361B2 (ja) * 2014-12-16 2020-09-09 ボード オブ リージェンツ オブ ザ ユニバーシティ オブ ネブラスカ 若年型バッテン病のための遺伝子療法
CA3016314A1 (en) * 2016-03-02 2017-09-08 Julianne REIDERS Therapy for frontotemporal dementia
TWI601821B (zh) * 2016-04-15 2017-10-11 中央研究院 治療神經發展性疾病
WO2020081490A1 (en) * 2018-10-15 2020-04-23 Voyager Therapeutics, Inc. EXPRESSION VECTORS FOR LARGE-SCALE PRODUCTION OF rAAV IN THE BACULOVIRUS/Sf9 SYSTEM

Similar Documents

Publication Publication Date Title
CN106488984B (zh) 一种治疗周围神经病变以及运动神经元疾病的方法
IL300294A (en) Gene therapy using nucleic acid constructs containing methyl CPG-binding protein 2 (MECP2) promoter sequences
JP2022060228A5 (cg-RX-API-DMAC7.html)
IL278213B1 (en) A gene therapy vector encoding an e3 ubiquitin protein ligase (park2) and use thereof in treating or inhibiting the onset of parkinson’s disease (pd)
JP7853952B2 (ja) Glut1発現のためのアデノ随伴ウイルスベクターおよびその使用
JP2022535749A5 (cg-RX-API-DMAC7.html)
US20240318199A1 (en) Adeno-associated virus (aav) systems for treatment of progranulin associated neurodegenerative diseases or disorders
JP2022541070A5 (cg-RX-API-DMAC7.html)
JP2023537625A5 (cg-RX-API-DMAC7.html)
RU2018145010A (ru) Оптимизированные гены и экспрессионные кассеты cln1, и их применение
JP2022511453A5 (cg-RX-API-DMAC7.html)
JP2024177670A (ja) 神経変性疾患のための遺伝子治療
JP2020519629A5 (cg-RX-API-DMAC7.html)
JP2020054367A (ja) 改変g6pcをコードするアデノ随伴ウイルスベクターおよびその使用
IL262852B1 (en) Treatment of complement-mediated disorders
JP2017529395A5 (cg-RX-API-DMAC7.html)
FI3373980T3 (fi) Menetelmiä lihasdystrofian hoitamiseksi
JP2020509786A5 (cg-RX-API-DMAC7.html)
JP2022553307A5 (cg-RX-API-DMAC7.html)
JP2021520811A5 (cg-RX-API-DMAC7.html)
JP2023500793A5 (cg-RX-API-DMAC7.html)
JP2021534766A5 (cg-RX-API-DMAC7.html)
CN114144518A (zh) 用于基因疗法的双亮氨酸拉链激酶抑制剂
WO2020127813A1 (en) Expression cassettes for gene therapy vectors
JP2025514489A5 (cg-RX-API-DMAC7.html)